Validation of SaaS / Cloud-Hosted GxP Systems & Infrastructure

Qualification of Virtual Machines and Containers for GxP Applications Qualification of Virtual Machines and Containers for GxP Applications As the pharmaceutical industry accelerates its adoption of digital transformation, the implementation of virtual machines (VMs) and containers has become increasingly prevalent for GxP (Good Practice) applications. However, this shift necessitates clear regulatory understanding and compliance with the guidance provided by regulatory…

Hybrid Cloud and On Premise Architectures CSV Considerations Hybrid Cloud and On Premise Architectures CSV Considerations In today’s pharmaceutical landscape, the integration of hybrid cloud solutions alongside traditional on-premise architecture presents numerous challenges and opportunities for Computer System Validation (CSV) professionals. With the increasing prevalence of regulatory scrutiny by agencies such as the FDA, EMA, and MHRA, it is vital…

Inspection Ready Cloud Validation Dossiers for FDA, EMA and MHRA Inspection Ready Cloud Validation Dossiers for FDA, EMA and MHRA In the rapidly evolving landscape of pharmaceutical manufacturing and technology, the need for robust validation processes is more critical than ever. As organizations increasingly turn to cloud-based systems and Software as a Service (SaaS) solutions, ensuring compliance with regulatory requirements…

Network Segmentation and Connectivity Validation for Cloud GxP Systems Network Segmentation and Connectivity Validation for Cloud GxP Systems In the realm of pharmaceutical manufacturing and data management, compliance with regulatory expectations is paramount. One area attracting increasing scrutiny is the validation of cloud-hosted GxP systems, particularly concerning network segmentation and connectivity. Regulatory agencies such as the US FDA, EMA, MHRA,…